Schiller Australia Schiller

With Easter right on our tails, the allure to consume your weight in chocolate Easter eggs can become almost impossible to resist!

With its smooth, creamy texture, and that sweet, sweet release of dopamine into the brain. Not to mention its gut healing anti-inflammatory properties… Wait what?

No it’s true. According to researcher unveiled at the 247th National Meeting & Exposition of the American Chemical Society (ACS) in March, there is evidence that Dark Chocolate is good for us. And it's not just because it's high in antioxidants.

Researchers from Louisiana State University found that certain bacteria in the stomach gobble up dark chocolate and ferment it into anti-inflammatory compounds that are good for your heart!

Isn’t this just wonderful news?!

According to Maria Moore, an undergraduate student and one of the study's researcher Scientists found that there are two kinds of microbes in the gut: the 'good' ones and the 'bad' ones. The good microbes, such as Bifidobacterium and lactic acid bacteria, feast on chocolate.

When you eat dark chocolate, they grow and ferment it, producing compounds that are anti-inflammatory.

The other bacteria in the gut are associated with inflammation and can cause gas, bloating, diarrhea and constipation. These include some Clostridia and some E. coli.

When these compounds are absorbed by the body, they lessen the inflammation of cardiovascular tissue, reducing the long-term risk of stroke

So not only does it tastes delightful it is actually good for your heart.

Finally a heart healthy practice I can get behind 110%!

Now if you’ll excuse me I have two dozen Easter Eggs to consume. They're not all for me, they are for my heart too. 

Happy holidays!

World Congress of Cardiology 2014 - 4th - 7th May 2014 - Stand J1 - Melbourne Exhibition Centre

In less than a month now Product Managers Mathias Haeflinger and Phillip Staudinger from SCHILLER International in Switzerland, land in Australia and bring with them the latest and greatest, cutting-edge software – The HyperQ!

This revolutionary new software provides cardiologists with a low-cost, non-invasive, radiation-free and highly reliable solution in the detection and evaluation of Coronary Artery Disease (CAD) and Acute Coronary Syndrome (ACS).

As part of our exhibition at The World Heart Federation's WCC 2014, we would like to personally invite you to this Australian first, one-on-one presentation.

Simply share the invitation at the head of this post, then visit us at Stand J1 for a personal presentation of the HyperQ software, and witness first hand how this ground-breaking technology may assist you in your practice.

 

 

Like it or not, daylight savings is due to strike again this Sunday night. With the summer stretch ending in NSW at 3am on April 6, New South Welshman across the state have less than a week until they flip their clocks back an hour and gain what feels like an extra hours sleep.

But is it just our sleep cycle that is affected by these time changes?

According to the Sydney Morning Herald, a study in the US has discovered that a combination of switching to daylight saving time, and losing one hour of sleep, raised the risk of having a heart attack the following Monday by 25 per cent, compared with other Mondays.

The good news for us is that by contrast, heart attack risk fell 21 per cent after the clock was returned to standard time, and people got an extra hour’s sleep the following Tuesday.

The not-so-subtle impact of moving the clock forward and backward was seen in a comparison of hospital admissions from a database of non-federal Michigan hospitals. It examined admissions before the start of daylight saving time and the Monday immediately after, for four consecutive years.

In general, heart attacks historically occur most often on Monday mornings, possibly due to the stress of starting a new workweek and inherent changes in our sleepwake cycle.

Proving yet again that sleep and stress are two major contributors to cardiac health. 

You can read the full report from Dr Amneet Sandhu, a cardiology fellow at the University of Colorado, via the Sydney Morning Herald here.

According to new research recently published in the British Medical Journal, diets low in saturated fat do not in fact curb heart disease risk or help you live longer.

The study conducted by Dr James DiNicolantonio, a leading US cardiovascular research scientist and doctor of pharmacy claims that,

Advice to replace saturated fats with carbohydrates or omega 6-rich polyunsaturated fats is based on flawed and incomplete data from the 1950s

DiNicolantonio points out that the demonization of saturated fats dates back to 1952, when research suggested a link between high dietary saturated fat intake and deaths from heart disease.

However new evidence has come to light that the author of this study drew his conclusions on data from six countries, choosing to ignore the data from a further 16, which didn't fit with his hypothesis, and which subsequent analysis of all 22 countries' data disproved.

The original theory claimed that since these fats increase total cholesterol, they must also increase heart disease risk. As food high in fat holds the highest calorie density, the thinking was that reducing intake would naturally curb obesity, diabetes, and metabolic syndrome.

But the evidence, which continues to mount, suggests otherwise. Dr James DiNicolantonio believes there is now a strong argument in favour of the consumption of refined carbohydrates as the causative dietary factor behind the surge in obesity and diabetes.

While a low fat diet may lower 'bad' (LDL) cholesterol, there are two types of LDL cholesterol. Switching to carbs may increase pattern B (small dense) LDL, which is more harmful to heart health than pattern A (large buoyant) LDL, as well as creating a more unfavourable overall lipid profile.

Several other studies indicate that a low carb diet is better for weight loss and lipid profile than a low fat diet, while large observational studies have not found any conclusive proof that a low fat diet cuts cardiovascular disease risk.

If you would like to learn more about Dr James DiNicolantonio's study, you can read the full article published in the BMJ-British Medical Journal here.

Well it’s been only three days since I left Malaysia and the 21st Schiller Asia Pacific Distributors conference, so I am still ever so slightly jet lagged.

However recovery time shall just have to wait until after I get you as jazzed up as we are about two new SCHILLER products Mat and I were introduced in Kula Lumpur.

The Asia Pacific Conference was well attended with representatives from all over the Asia Pacific region, as well as some really good input by two senior representatives from Schiller Switzerland.

Although it was a man by the name of Doctor Yair Granot from BSP Medical in Israel that really caught my eye. Yair introduced the company to an incredible piece of software called the HyperQ.

The HyperQ is the result of groundbreaking technology that provides Cardiologists a unique solution to the detection and evaluation of Coronary Artery Disease (CAD) and Acute Coronary Syndrome.

We are very excited about this new software as it will provide private cardiology practices and departments a low-cost, noninvasive, radiation-free and most importantly highly reliable solution.

The other item that caught our interest was a brand new Stress Test system called CS-200 Touch. This is the next generation of Exercise Stress Test Systems. With its modern ergonomic design and height adjustable trolley; the CS-200 Touch will fit into any small space you require at the same time as functioning as a superb diagnostic tool. Hopefully, this image will whet your appetites.

I look very forward to talking with you more about the HyperQ and the CS-200 Touch at the World Congress of Cardiology in Melbourne in early May.

If you would like further information on either of these new products before then call me directly at the office on 02) 4954 2442.

Regards,

Harry Packer

 

 

 

 

 

 

 

 

 

Up until now Coronary Artery Disease (CAD) screening has been largely based on stress ECG testing that has a limited diagnostic
 accuracy, especially in women.

Additionally, there
 are growing concerns over exposure to radiation and
 cutbacks on payment for costly cardiac imaging.

However with the introduction of the HyperQ, those issues are a thing of the past.

The groundbreaking HyperQ technology with superior
 accuracy provides a unique solution for the detection
 and evaluation of Coronay Artery Disease (CAD) and
 Acute Coronary Syndrome (ACS).


HyperQ stress ECG testing provides a low-cost, noninvasive,
 radiation-free and highly reliable first line CAD
 diagnostic solution for private cardiology practices as
 well as cardiology departments in hospitals.

HyperQ is
 based on solid scientific and clinical research and is 
FDA-cleared and CE-marked.

If you'd like further information of the revolutionary HyperQ, simply call our office on 4954 2442 and our freindly staff will gladly answer your queries.